CSF, Paraneoplastic, Autoantibody Evaluation
Build info
Synonyms
PARANEOPLASTIC AUTOANTIBODY EVALUATION, SPINAL
PARANEOPLASTIC AB EVAL, CSF PARANCSF
LAB11498
Short Name
PARANEOPLASTIC AUTOANTIBODY EVALUATION, SPINAL
Procedure Master Number
LAB11498
Procedure ID
115319
Clinical Info
Aids in the diagnosis of paraneoplastic neurological autoimmune disorders related to carcinoma of lung, breast, ovary, thymoma, or Hodgkin lymphoma in spinal fluid specimens
Specimen Type
CSF
Container
Sterile
Collection Instructions
Container/Tube: Sterile vial Specimen : 4 mL CSF (2 mL min) Transport Temperature: Refrigerated Stability: Refrigerated (preferred) - 28 days Frozen - 28 days Ambient - 72 hours
Transport Instructions
Refrigerated
Specimen Stability
Refrigerated (preferred) - 28 days Frozen - 28 days Ambient - 72 hours
Methodology
ANN1C, ANN2C, ANN3C, PCA1C, PCA2C, PCTRC, AMPHC, CRMC, AGN1C, NMDIC, AMPIC, GABIC, DPPIC, DPPTC, GL1IC, GL1TC: Indirect Immunofluorescence Assay (IFA) WBNC, ABLTC, CRMWC: Western Blot VGKCC: Radioimmunoassay (RIA) DPPCC, NMDCC, AMPCC, GABCC, GL1CC, LG1CC, CS2CC: Cell-Binding Assay (CBA) GD65C: Immunoprecipitation Assay (IPA)
Days Performed
AGN1C, ANN1C, ANN2C, ANN3C, PCA1C, PCA2C, PCTRC, AMPHC, CRMC, AMPIC: Monday through Friday; 11:30 a.m. and 8 p.m.; Saturday, Sunday; 8 a.m. WBNC, CRMWC, ABLTC: Monday, Wednesday, Friday; 8 a.m. NMDCC, AMPCC, GABCC, LG1CC, CS2CC: Monday through Friday; 6 a.m. DPPCC, GL1CC: Monday through Thursday, Sunday; 6 p.m. GD65C: Monday through Friday; 6 a.m. and 4 p.m. VGKCC: Monday through Friday 11 a.m. and 6 p.m.; Saturday, Sunday 6 a.m.
Performing Laboratory
Mayo Medical Laboratories
CPT
86255 x 9 83519 (if appropriate) 84182 x 3 (if appropriate) 86255 x 9 (if appropriate) 86256 x 5 (if appropriate) 86341 (if appropriate) ;
PDM
1659071
Results
Component Name
Base Name
Common Name
External Name
AMPHIPHYSIN AB, CSF
AMPHIPHYABC
AMPHIPHYSIN AB, CSF
Amphiphysin Ab, Csf
ANTI-GLIAL NUCLEAR AB, TYPE 1
GLIALNUCAB1
ANTI GLIAL NUCLEAR AB, TYPE 1
Anti-Glial Nuclear Ab, Type 1
ANTI-NEURONAL NUCLEAR AB, TYPE 1
ANNAB
ANTI NEURONAL NUCLEAR AB, TYPE 1
Anti-Neuronal Nuclear Ab, Type 1
ANTI-NEURONAL NUCLEAR AB, TYPE 2
ANNAB
ANTI NEURONAL NUCLEAR AB, TYPE 2
Anti-Neuronal Nuclear Ab, Type 2
ANTI-NEURONAL NUCLEAR AB, TYPE 3
ANNAB
ANTI NEURONAL NUCLEAR AB, TYPE 3
Anti-Neuronal Nuclear Ab, Type 3
CRMP-5-IGG, CSF
CRMP5IGGCSF
CRMP 5 IGG, CSF
Crmp-5-Igg, Csf
IFA NOTES
IFANOTES
IFA NOTES
Ifa Notes
PARANEOPLASTIC INTERPRETATION, CSF
PARAINTCSF
PARANEOPLASTIC INTERPRETATION, CSF
Paraneoplastic Interpretation, Csf
PURKINJE CELL CYTOPLASMIC AB TYPE 1
PURCYTO1
PURKINJE CELL CYTOPLASMIC AB TYPE 1
Purkinje Cell Cytoplasmic Ab Type 1
PURKINJE CELL CYTOPLASMIC AB TYPE 2
PURCYTO2
PURKINJE CELL CYTOPLASMIC AB TYPE 2
Purkinje Cell Cytoplasmic Ab Type 2
PURKINJE CELL CYTOPLASMIC AB TYPE TR
PURCYTOTR
PURKINJE CELL CYTOPLASMIC AB TYPE TR
Purkinje Cell Cytoplasmic Ab Type Tr